News

Treating patients with cancer is often challenging yet rewarding work. But caring for patients in an urban setting, where some patients don’t speak English and other patients aren’t fully insured and possibly facing significant financial challenges.

Here’s how community oncologists seize opportunities to improve the quality of care and create performance metrics.

Montefiore Medical Center in Bronx, New York, is participating in CMS’ oncology care model, a value-based payment arrangement. Find out what new group of staff members is helping it succeed.

Analysis from Avalere shows why healthcare execs should understand how oncology practices are evolving in response to the OCM.

FDA is warning that 2 liquid-filled intragastric balloon systems used to treat obesity are causing deaths in some patients

FDA’s new guidances on Risk Evaluation and Mitigation Strategy (REMS) requirements aims to help generic and biosimilar drugs get to market faster.

A survey from EY reveals how consumers use technology and how to mix engagement tools and existing EHR features.

Using EHRs and other technologies can enhance care coordination, patient engagement.

Many healthcare organizations are expanding leadership roles to help meet business and patient-centered goals.

A Canadian study has exciting findings about offspring exposed to tumor necrosis factors.

Legislation removes FDA involvement when patients seek experimental medications. Here’s what critics and proponents say.

Experts say Anthem’s acquisition of Aspire Health, the nation’s biggest non-hospice, community-based palliative care provider, continues the health insurer race to dominate this kind of health experience.

In a decision reached through the joint FDA/CMS Parallel Review process, CMS has granted national Medicare coverage to next-generation sequencing tests approved or cleared by the FDA as companion diagnostics for cancer therapies. This is clearly a win for Medicare beneficiaries and some NGS test providers-but is it also good news for MCOs?

A network of value-based care programs from the Blue Cross Blue Shield Association emphasizes quality instead of quantity of medical services provided.

Major depression diagnoses have risen, according to a study of medical claims by the Blue Cross Blue Shield Association. Find out which populations suffer the most.

For far too long, chart chasing was the best method health plans had to improve HEDIS® measures and Medicare Star ratings. Now, there is a better way.

We’ve detailed 10 proven ways all health plans can put into practice now to improve scores this HEDIS® season.

Have two minutes? Listen to this quick podcast for critical takeaways from three of our top articles.

Healthcare organizations should focus on these things to improve health management of COPD patients and reduce costs.

FDA is asking manufacturers to immediately stop selling OTC products containing the pain reliever benzocaine (such as Orajel) for teething in infants or children.

While the pharmaceutical industry has made tremendous advances in new drug development this year, FDA has also had to remove drugs from the market or investigate problem drugs. Here are the top 3 drug warnings and problems so far in 2018.

Two studies from the University of Minnesota’s School of Public Health has interesting findings about primary care among low-income patients enrolled in a Medicaid ACO.

Two experts highlight noteworthy updates in the transplant and cellular therapy space. Read more.

The Center for Blood and Cancer Disorders in Fort Worth, Texas, is participating in many value-based contracts. Here’s how it is successful.

A new study explored racial/ethnic differences in healthcare outcomes among patients receiving home healthcare. Here are the shocking results.